Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Global Heart
|
November 16, 2022
Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
Dorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Global Heart
|
July 15, 2022
Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
Dorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Journal of Human Hypertension
|
February 29, 2024
ACHIEVE conference proceedings: implementing action plans to reduce and control hypertension burden in Africa
Paul Olowoyo, Anastase Dzudie, Akinkunmi Paul Okekunle, et al.
Global Heart
|
November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of Hypertension
Abdul Salam, H Asita de Silva, Dike Ojji, et al.
The New England Journal of Medicine
|
September 3, 2014
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis
Bongani M Mayosi, Mpiko Ntsekhe, Jackie Bosch, et al.
Journal of the American Heart Association
|
December 22, 2021
Registry for Acute Coronary Events in Nigeria (RACE-Nigeria): Clinical Characterization, Management, and Outcome
Simeon Isezuo, Mahmoud Umar Sani, Abdullahi Talle, et al.
American Heart Journal
|
January 29, 2013
Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis
Bongani M Mayosi, Mpiko Ntsekhe, Jackie Bosch, et al.
Cardiovascular Journal of Africa
|
January 28, 2016
Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué
David Watkins, Liesl Zuhlke, Mark Engel, et al.
European Heart Journal
|
November 27, 2014
Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)
Liesl Zühlke, Mark E Engel, Ganesan Karthikeyan, et al.
Circulation
|
October 6, 2016
Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)
Liesl Zühlke, Ganesan Karthikeyan, Mark E Engel, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Global Heart
|
November 16, 2022
Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
Dorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Global Heart
|
July 15, 2022
Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
Dorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Journal of Human Hypertension
|
February 29, 2024
ACHIEVE conference proceedings: implementing action plans to reduce and control hypertension burden in Africa
Paul Olowoyo, Anastase Dzudie, Akinkunmi Paul Okekunle, et al.
Global Heart
|
November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of Hypertension
Abdul Salam, H Asita de Silva, Dike Ojji, et al.
The New England Journal of Medicine
|
September 3, 2014
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis
Bongani M Mayosi, Mpiko Ntsekhe, Jackie Bosch, et al.
Journal of the American Heart Association
|
December 22, 2021
Registry for Acute Coronary Events in Nigeria (RACE-Nigeria): Clinical Characterization, Management, and Outcome
Simeon Isezuo, Mahmoud Umar Sani, Abdullahi Talle, et al.
American Heart Journal
|
January 29, 2013
Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis
Bongani M Mayosi, Mpiko Ntsekhe, Jackie Bosch, et al.
Cardiovascular Journal of Africa
|
January 28, 2016
Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué
David Watkins, Liesl Zuhlke, Mark Engel, et al.
European Heart Journal
|
November 27, 2014
Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)
Liesl Zühlke, Mark E Engel, Ganesan Karthikeyan, et al.
Circulation
|
October 6, 2016
Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)
Liesl Zühlke, Ganesan Karthikeyan, Mark E Engel, et al.
Page
of 7